The ARA Theranostics Center has been designed specifically to enable radiopharmaceutical imaging and treatment to be conducted in a safe and comfortable environment. We have PET/CT, SPECT/CT, and regular scintigraphy for radiopharmaceutical imaging. Specialized therapy rooms, where patients can relax with their own restroom, WiFi, and television, are dedicated to radiopharmaceutical treatment and imaging. ARA molecular radiologists offer consultations in-house or by telehealth, depending on patient preference.
A History of Excellence
ARA has a long history dating back to the 1960s of using radiopharmaceuticals to image and treat disease, starting with the use of I-131 radioiodine to image and treat overactive thyroid gland (hyperthyroidism) and thyroid cancer. The Theranostics Center has been proud to offer the latest radiopharmaceuticals for imaging and treatment as they have become available over the years. Our long experience, high-tech facility, and clinical expertise in radiopharmaceuticals ensures the best possible outcome for our patients.
In September 2022, the ARA Theranostics Center was certified as a Center of Excellence in Radiopharmaceutical Therapy by the Society of Nuclear Medicine and Molecular Imaging (SNMMI). To gain this certification, the Center had to meet strict regulatory, training, qualification, experience, and performance criteria to assure that rigorous protocols are in place and followed, leading to appropriate patient selection and optimal treatment outcomes from radiopharmaceutical therapy.
Thank you for visiting our website. We look forward to the opportunity of helping you with your imaging and treatment needs.
Learn more about ARA’s Theranostics treatments:
For information on ARA’s advanced molecular imaging that does not have a treatment component, please visit our molecular radiology exam section.
